PubRank

René Drucker-Colín

Author PubWeight™ 30.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats. Behav Brain Res 2006 1.09
2 Dynamics of the Parkinsonian striatal microcircuit: entrainment into a dominant network state. J Neurosci 2010 1.05
3 Mechanisms of nicotine actions on dorsal raphe serotoninergic neurons. Eur J Pharmacol 2002 0.91
4 Prism adaptation in spinocerebellar ataxia type 2. Neuropsychologia 2007 0.91
5 Effects of rTMS on Parkinson's disease: a longitudinal fMRI study. J Neurol 2011 0.90
6 Long-term changes in sleep and depressive symptoms of smokers in abstinence. Nicotine Tob Res 2007 0.90
7 Nonoccupational environmental exposure to manganese is linked to deficits in peripheral and central olfactory function. Chem Senses 2013 0.86
8 Olfactory dysfunction in hereditary ataxia and basal ganglia disorders. Neuroreport 2003 0.84
9 Neuronal precursors within the adult rat subventricular zone differentiate into dopaminergic neurons after substantia nigra lesion and chromaffin cell transplant. J Neurosci Res 2006 0.83
10 Narcolepsy and orexins: an example of progress in sleep research. Front Neurol 2011 0.83
11 Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats. FEBS Lett 2006 0.82
12 Survival rates through time of hypocretin grafted neurons within their projection site. Neurosci Lett 2006 0.82
13 Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression. Brain Res Bull 2008 0.81
14 The nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent. Behav Neurosci 2008 0.81
15 Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats. PLoS One 2011 0.81
16 Is nicotine protective against Parkinson's disease? An experimental analysis. CNS Neurol Disord Drug Targets 2012 0.81
17 Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions. J Neurochem 2014 0.81
18 Effect of transcranial magnetic stimulation on oxidative stress induced by 3-nitropropionic acid in cortical synaptosomes. Neurosci Res 2006 0.80
19 Sleep deprivation induces differential morphological changes in the hippocampus and prefrontal cortex in young and old rats. Synapse 2014 0.79
20 Odor memory stability after reinnervation of the olfactory bulb. PLoS One 2012 0.79
21 Growth hormone improves hippocampal adult cell survival and counteracts the inhibitory effect of prolonged sleep deprivation on cell proliferation. Brain Res Bull 2011 0.79
22 Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats. Life Sci 2011 0.78
23 Fullerene C60 and ascorbic acid protect cultured chromaffin cells against levodopa toxicity. J Neurosci Res 2003 0.78
24 Transcranial magnetic stimulation attenuates cell loss and oxidative damage in the striatum induced in the 3-nitropropionic model of Huntington's disease. J Neurochem 2006 0.78
25 Global actions of nicotine on the striatal microcircuit. Front Syst Neurosci 2013 0.78
26 Effect of nicotine on 3-nitropropionic acid-induced oxidative stress in synaptosomes. Eur J Pharmacol 2004 0.78
27 Protective effect of nicotine on oxidative and cell damage in rats with depression induced by olfactory bulbectomy. Eur J Pharmacol 2009 0.77
28 Effects of nicotine on alcohol intake in a rat model of depression. Pharmacol Biochem Behav 2002 0.77
29 Effects of long-term administration of nicotine and fluoxetine on sleep in depressed patients. Arch Med Res 2005 0.77
30 Transcranial magnetic stimulation reduces nociceptive threshold in rats. J Neurosci Res 2012 0.77
31 Promoting of wakefulness by administrations of modafinil into anterior hypothalamus and into the pedunculopontine tegmental nucleus in rats. Neurosci Lett 2008 0.77
32 Antioxidant-like effects and protective action of transcranial magnetic stimulation in depression caused by olfactory bulbectomy. Neurochem Res 2010 0.76
33 Unilateral olfactory deficit in a hemiparkinson's disease mouse model. Neuroreport 2014 0.76
34 Extremely low-frequency electromagnetic fields activate the antioxidant pathway Nrf2 in a Huntington's disease-like rat model. Brain Stimul 2012 0.76
35 2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats. Pharmacol Biochem Behav 2013 0.76
36 Mouse embryonic stem cell-derived cells reveal niches that support neuronal differentiation in the adult rat brain. Stem Cells 2015 0.76
37 Infusion of modafinil into anterior hypothalamus or pedunculopontine tegmental nucleus at different time-points enhances waking and blocks the expression of recovery sleep in rats after sleep deprivation. Exp Neurol 2011 0.76
38 Cellular viability effects of fatty acid amide hydrolase inhibition on cerebellar neurons. Int Arch Med 2011 0.75
39 Reply to 'Physician, heal thyself'. Nat Med 2006 0.75
40 Adrenalectomy and dexamethasone replacement on yawning behavior. Behav Brain Res 2004 0.75
41 Chromaffin cell transplant in spinal cord reduces secondary allodynia induced by formalin in the rat. Role of opioid receptors and α₂-adrenoceptors. Eur J Pharmacol 2011 0.75
42 Chromaffin cell transplants: from the lab to the clinic. Life Sci 2012 0.75
43 Models for narcolepsy with cataplexy drug discovery. Expert Opin Drug Discov 2012 0.75